CRY1 antibody (N-Term)
Quick Overview for CRY1 antibody (N-Term) (ABIN7468176)
Target
See all CRY1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Human
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of human CRY1. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: HeLa Validation: Orthogonal
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.19 mg/mL
-
Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- CRY1 (Cryptochrome 1 (Photolyase-Like) (CRY1))
-
Alternative Name
- cryptochrome circadian regulator 1
-
Background
- Cryptochrome circadian regulator 1 , DSPD , PHLL1
-
Molecular Weight
- 66 kDa
-
Gene ID
- 1407
-
UniProt
- Q16526
-
Pathways
- Response to Water Deprivation, Proton Transport
Target
-